Thyroid Cancer Clinical Trials - International Thyroid Oncology Group
Clinical trials play a critical role in advancing new therapies and improving standards of care.
This page provides access to publicly available information on active and recruiting clinical trials for thyroid cancer, offering researchers, clinicians, and patients a platform to explore trial eligibility, design, and geographic availability, while encouraging philanthropic support for innovative research in advanced thyroid cancers.
The information helps patients and healthcare professionals identify suitable clinical studies, fostering participation in evidence‑based research that can lead to improved treatment options and outcomes for thyroid cancer.
Evidence level: Feltételezés / hírjelzés. Nincs önálló tudományos bizonyíték.
Related signals
- The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma
- The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancer
- Improving predicted risk of recurrence using molecular profiling in papillary thyroid cancer
- Global Burden of Thyroid Cancer in Adults Age 15‑49 Years and Its Predictions: Findings From Global Burden of Disease Study 2021
- Thyroid Cancer: Pathogenesis, Clinicopathology, Diagnosis, and Management